| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/26/2008 | WO2008074697A1 Polymorphs of a mglur5 receptor antagonist |
| 06/26/2008 | WO2008074686A1 Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests |
| 06/26/2008 | WO2008074515A1 Novel hetaryl-phenylene-diamine pyrimidine as protein kinase inhibitors |
| 06/26/2008 | WO2008074450A2 Non-peptidic renin inhibitors nitroderivatives |
| 06/26/2008 | WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |
| 06/26/2008 | WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 06/26/2008 | WO2008011154A3 Formulations for benzimidazolyl pyridyl ethers |
| 06/26/2008 | WO2008002820A3 Substituted benzyl amine compounds |
| 06/26/2008 | WO2006108791A3 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides |
| 06/26/2008 | US20080154041 Producing such as 3-ethynyl-5-(1-methylpyrrolidin-2-yl)pyridine; intermediates for synthesis of nicotinic acetylcholine receptor modulators |
| 06/26/2008 | US20080153878 5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one ; for therapy of Alzheimer's disease, myasthenia gravis, Huntingtons disease or glaucoma |
| 06/26/2008 | US20080153875 Novel indole derivatives and their use as medicament |
| 06/26/2008 | US20080153872 Bis-(Coumarin) Compounds With Anti-Inflammatory Activity |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153857 Specific capsaicin receptor modulators; analgesics; neuropathic pain; obesity; antitussives, hiccups; e.g. (4-Cyclopropyl-phenyl)-[2-methoxymethyl-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl]-amine |
| 06/26/2008 | US20080153851 Cycloalkyl Piperidine Tachykinin Receptor Antagonists |
| 06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
| 06/26/2008 | US20080153844 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 06/26/2008 | US20080153838 Compounds Having Tie2 (Tek) Activity |
| 06/26/2008 | US20080153837 4-(Benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene derivatives; treating disorders related to Hsp90 protein; anticarcinogenic, antimetastasis, antitumor, anticoagulant, antiproliferative, antihistamine, and antidiabetic agents; metabolic, muscular, rheumatic and nervous system disorders |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | US20080153817 Treatment for Alzheimer's Disease and Related Conditions |
| 06/26/2008 | US20080153812 Novel compounds |
| 06/26/2008 | US20080153809 Novel amides useful for treating pain |
| 06/26/2008 | US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators |
| 06/26/2008 | US20080153778 5-(Methoxymethyl)-1-(5-methyl-4-(thiophen-2-yl)pyrimidin-2-yl)-N-(pyridin-4-ylmethyl)-1H-pyrazole-4-carboxamide; for the treatment or prevention of type 2 diabetes and type 2 diabetes-related conditions |
| 06/26/2008 | US20080149097 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB |
| 06/26/2008 | DE102007003036A1 Pyrimidinylpyrazole Pyrimidinylpyrazole |
| 06/26/2008 | CA2673582A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 06/26/2008 | CA2673444A1 Polymorphs of a mglur5 receptor antagonist |
| 06/26/2008 | CA2673359A1 Cb1 receptor modulators |
| 06/26/2008 | CA2673358A1 Pyrazole derivatives as modulators of cannabinoid receptor |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2673177A1 Modulators of cb1 receptors |
| 06/26/2008 | CA2673119A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors |
| 06/26/2008 | CA2672893A1 Triazine derivatives and their therapeutical applications |
| 06/26/2008 | CA2672814A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| 06/26/2008 | CA2672673A1 O-linked pyrimidin-4-amine-based compounds, compositions comprising them and methods of their use |
| 06/26/2008 | CA2672661A1 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | CA2672521A1 Pyrazole derivatives as protein kinase inhibitors |
| 06/26/2008 | CA2672269A1 Organic compounds |
| 06/26/2008 | CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/25/2008 | EP1935891A1 Crystalline forms of rabeprazole sodium |
| 06/25/2008 | EP1935890A1 2-heteroaryl-substituted indole derivative |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1934202A2 Nicotinic acid and picolinic acid derived near-infrared fluorophores |
| 06/25/2008 | EP1934201A1 Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
| 06/25/2008 | EP1934200A1 Tyrosine kinase inhibitors |
| 06/25/2008 | EP1934199A2 Indane derivatives as mch receptor antagonists |
| 06/25/2008 | EP1934198A2 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 06/25/2008 | EP1934187A1 Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors |
| 06/25/2008 | EP1934186A2 Renin inhibitors nitroderivatives |
| 06/25/2008 | EP1934181A2 Kinase inhibitors |
| 06/25/2008 | EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 06/25/2008 | EP1933836A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/25/2008 | EP1933622A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 06/25/2008 | EP1861389B1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
| 06/25/2008 | EP1807398B1 New indole or benzimidazole derivatives |
| 06/25/2008 | EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders |
| 06/25/2008 | EP1606266A4 Chemical compounds |
| 06/25/2008 | EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/25/2008 | EP1560834B1 New tricyclic derivatives as ltd4 antagonists |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/25/2008 | CN101208334A Novel cyclic amines |
| 06/25/2008 | CN101208332A Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase |
| 06/25/2008 | CN101208331A Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 06/25/2008 | CN101208330A Method of preparing esomeprazole and salts thereof |
| 06/25/2008 | CN101208329A Pyrimidine derivatives and their use in the treatment of cancer |
| 06/25/2008 | CN101208328A Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 06/25/2008 | CN101208327A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/25/2008 | CN101208311A Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/25/2008 | CN101208303A CGRP receptor antagonists |
| 06/25/2008 | CN101208302A Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/25/2008 | CN101208094A Pharmacokinetically improved compounds |
| 06/25/2008 | CN101205243A Chloride 2-(6'-imine pyridyl) benzimidazole metal complex as well as preparation method and uses thereof |
| 06/25/2008 | CN100396680C Vla-4 inhibitors |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396676C Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 06/25/2008 | CN100396675C Prodrugs of proton pump inhibitors |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390907 Vanilloid receptor ligands and their use in treatments |
| 06/24/2008 | US7390904 Hydrogen peroxide catalyzed process for the preparation of sterically hindered N-hydrocarbyloxyamines |
| 06/24/2008 | US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/24/2008 | US7390822 Delta-2 opioid receptor agonists; protecting cardiac and cerebral organs |
| 06/24/2008 | US7390820 Substituted quinolinone derivatives and methods of use |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390813 Metabolic syndrome and lipid metabolism, especially diseases of fatty acid and cholesterol metabolism, such as those mediated by stearoyl-CoA desaturase |
| 06/24/2008 | US7390811 Respiratory syncytial virus replication inhibitors |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/24/2008 | US7390804 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |